CHI Advisors as of Sept. 30, 2022
Portfolio Holdings for CHI Advisors
CHI Advisors holds 25 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Prometheus Biosciences | 25.4 | $95M | 1.6M | 59.01 | |
Pliant Therapeutics (PLRX) | 19.2 | $71M | 3.4M | 20.89 | |
Cullinan Oncology (CGEM) | 11.2 | $42M | 3.2M | 12.82 | |
Repare Therapeutics Ord (RPTX) | 10.0 | $37M | 3.1M | 12.13 | |
Vectivbio Hldg Ord Shs | 6.6 | $25M | 4.1M | 6.00 | |
Kezar Life Sciences (KZR) | 4.1 | $15M | 1.8M | 8.61 | |
Larimar Therapeutics (LRMR) | 2.9 | $11M | 3.4M | 3.20 | |
Akouos | 2.3 | $8.7M | 1.3M | 6.76 | |
2seventy Bio Common Stock (TSVT) | 2.1 | $7.7M | 530k | 14.55 | |
Keros Therapeutics (KROS) | 2.0 | $7.5M | 200k | 37.62 | |
Compass Therapeutics (CMPX) | 1.7 | $6.5M | 2.8M | 2.28 | |
Omega Therapeutics Common Stock (OMGA) | 1.5 | $5.7M | 1.1M | 5.42 | |
Inozyme Pharma (INZY) | 1.4 | $5.4M | 2.0M | 2.68 | |
Precision Biosciences Ord | 1.3 | $4.8M | 3.7M | 1.30 | |
Ikena Oncology (IKNA) | 1.2 | $4.3M | 1.2M | 3.55 | |
G1 Therapeutics | 1.1 | $4.0M | 324k | 12.49 | |
Orchard Therapeutics Spon Ads | 1.1 | $4.0M | 8.0M | 0.50 | |
Eiger Biopharmaceuticals | 0.9 | $3.4M | 455k | 7.53 | |
Freeline Therapeutics Hldgs Sponsored Ads | 0.9 | $3.4M | 4.8M | 0.70 | |
Rallybio Corp (RLYB) | 0.8 | $2.8M | 194k | 14.47 | |
Oncorus | 0.5 | $2.0M | 2.4M | 0.85 | |
Corvus Pharmaceuticals (CRVS) | 0.5 | $2.0M | 2.4M | 0.82 | |
Ovid Therapeutics (OVID) | 0.4 | $1.6M | 865k | 1.84 | |
Nkarta (NKTX) | 0.4 | $1.5M | 118k | 13.16 | |
Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 0.3 | $1.2M | 50k | 23.94 |